Kiromic BioPharma, Inc. (KRBPQ)
OTCMKTS · Delayed Price · Currency is USD
0.0040
0.00 (0.00%)
Aug 14, 2025, 4:00 PM EDT
Kiromic BioPharma Market Cap
Kiromic BioPharma has a market cap or net worth of $6.28 thousand as of August 15, 2025. Its market cap has decreased by -99.84% in one year.
Market Cap
6.28K
Enterprise Value
13.44M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since October 16, 2020, Kiromic BioPharma's market cap has decreased from 84.33M to 6.28K, a decrease of -99.99%. That is a compound annual growth rate of -86.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 6.28K | -99.54% |
| Dec 31, 2024 | 1.38M | 26.04% |
| Dec 29, 2023 | 1.09M | -66.79% |
| Dec 30, 2022 | 3.30M | -86.04% |
| Dec 31, 2021 | 23.62M | -61.97% |
| Dec 31, 2020 | 62.11M | -26.35% |
| Oct 16, 2020 | 84.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 798.20M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 598.01M |
| Elite Pharmaceuticals | 567.50M |
| Nika Pharmaceuticals | 360.27M |
| Northwest Biotherapeutics | 349.08M |
| American Oncology Network | 337.45M |
| CytoDyn | 325.38M |